Chlamydia trachomatis infectious disease
MONDO:0005701An infection that is caused by Chlamydia trachomatis.
Also known as: Chlamydia trachomatis caused disease or disorder, Chlamydia trachomatis disease or disorder, Chlamydial infection, chlamydia
54 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Which antibiotic wins the battle against chlamydia in teens?
Disease control CompletedThis trial tests two approved antibiotics—azithromycin (a single dose) and doxycycline (twice daily for a week)—to see which is more effective at curing genital chlamydia in young people aged 12-21 living in youth correctional facilities. Participants provide urine samples over a…
Phase: PHASE3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
A smartphone app takes on heavy drinking and STIs in high-risk men
Disease control CompletedThis trial tests whether a web-based app called Game Plan can help men who have sex with men reduce heavy drinking and sexually transmitted infections. Participants receive home HIV/STI self-testing kits and are randomly assigned to either a 24-hour helpline alone or the helpline…
Phase: NA • Sponsor: Brown University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Which antibiotic works best for hidden anal chlamydia?
Disease control CompletedThis study compared two common antibiotics—azithromycin (single dose) and doxycycline (7-day course)—for treating anal chlamydia in women who also had a vaginal chlamydia infection. The goal was to see which treatment clears the anal infection better, since anal chlamydia often g…
Phase: PHASE4 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a 3-Day antibiotic course beat the standard 7 days for chlamydia?
Disease control CompletedThis completed phase 4 trial tested whether taking doxycycline for 3 days works as well as the usual 7-day course for treating chlamydia. About 526 men and women with confirmed chlamydia took either a 3-day or 7-day regimen, with placebo pills used to keep the study blinded. Part…
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Antibiotic-Free future: study tests stopping trachoma treatment
Disease control CompletedThis study looked at whether it is safe to stop giving annual azithromycin to communities with low levels of trachoma, an eye infection that can cause blindness. Over 3,900 people in Niger took part. Researchers compared stopping treatment after at least 5 years versus continuing…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Eye drop may prevent eyelash regrowth after trachoma surgery
Disease control CompletedThis study tested whether a steroid eye drop (fluorometholone) given for four weeks after trachoma surgery could stop eyelashes from growing back and rubbing against the eye. Over 2,400 people aged 15 and older took part. The goal was to see if this simple, low-cost addition to s…
Phase: PHASE3 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New antibiotic shows promise for newborns with dangerous infections
Disease control CompletedThis study looked at how the antibiotic cefiderocol works in hospitalized infants under 3 months old with suspected or confirmed gram-negative bacterial infections. Researchers measured drug levels in the blood and checked for side effects in 30 babies. The goal was to find the r…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New antibiotic shows promise for kids with tough infections
Disease control CompletedThis study tested the safety and how the body processes the antibiotic cefiderocol in hospitalized children aged 3 months to 18 years with serious bacterial infections. The goal was to see if the drug is safe and how it works in the body. 53 children participated, and the study i…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New antibiotic shows promise for kids with tough infections
Disease control CompletedThis study tested a new antibiotic called MK-7655A in 115 children from birth to 18 years old who had serious bacterial infections. The goal was to see if the drug is safe and works better than standard treatments. Children were randomly assigned to receive either the new drug or…
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Rapid STI test aims to curb antibiotic misuse
Diagnosis CompletedThis study compares a new rapid point-of-care test for chlamydia, gonorrhea, and mycoplasma genitalium to standard lab testing. The goal is to see if the faster test helps doctors give the right antibiotics on the same day, reducing unnecessary or missed treatments. Participants …
Phase: NA • Sponsor: Hoffmann-La Roche • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Emergency room study aims to catch more STIs in teens
Diagnosis CompletedThis study looked at better ways to screen teenagers (ages 15-21) for chlamydia and gonorrhea when they visit emergency departments. Researchers compared offering STI tests to everyone versus only to those with certain risk factors. The goal was to find the most effective and cos…
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
New rapid tests aim to stop STIs in their tracks for pregnant women in zimbabwe
Diagnosis CompletedThis study tested a strategy of using rapid, point-of-care diagnostic tests for sexually transmitted infections (STIs) in pregnant women attending antenatal clinics in Zimbabwe. Over 1,000 women were offered testing for chlamydia, gonorrhea, trichomoniasis, syphilis, and hepatiti…
Phase: NA • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Could routine STI screening during pregnancy prevent preterm births?
Prevention CompletedThis study compares different ways of screening pregnant women for three common sexually transmitted infections (chlamydia, gonorrhea, and trichomonas) to see if treating these infections can reduce the risk of preterm birth and low birth weight. Over 2,200 pregnant women in Sout…
Phase: NA • Sponsor: Foundation for Professional Development (Pty) Ltd • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC
-
Can a pill and a vaccine stop STIs in High-Risk men?
Prevention CompletedThis study tested two strategies to prevent sexually transmitted infections (STIs) in men who have sex with men and already take HIV PrEP. One group took doxycycline pills after unprotected sex, and another group received a meningitis vaccine (Bexsero). The goal was to see if the…
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
Van clinic delivers lifesaving prevention to women at high risk
Prevention CompletedThis study tested a pop-up clinic inside a van for women who inject drugs and exchange sex in north Seattle. The goal was to see if offering HIV prevention pills, addiction medications, and quick STI testing in a convenient location would help more women start and stay on these t…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
Meth reduction may lower STI risk, small study suggests
Knowledge-focused CompletedThis completed study looked at 59 men who have sex with men and use methamphetamine. Researchers used a program that gives rewards for drug-free urine samples to help them cut back. They measured inflammation in the rectum and tracked STI/HIV risk behaviors over 8 weeks. The goal…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Massive ethiopian trial tests hygiene vs. antibiotics for blinding eye disease
Knowledge-focused CompletedThis large study in rural Ethiopia looked at whether providing clean water, sanitation, and face-washing education can reduce trachoma infections in communities that have already received many rounds of antibiotics. Over 47,000 people from 40 communities took part. The goal is to…
Phase: PHASE3 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Massive german study reveals hidden toll of chlamydia infections
Knowledge-focused CompletedThis study looked at health insurance records of over 81,000 people aged 14 to 44 in Germany to see how often chlamydia leads to serious health problems like infertility or pelvic disease, and how much it costs the healthcare system. Researchers tracked infections, complications,…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Paying it forward boosts STI testing in chinese men
Knowledge-focused CompletedThis study tested whether a pay-it-forward approach—where one person's donation covers testing for the next person—could increase gonorrhea and chlamydia testing among men in China. Over 1,200 men who had sex in the past year but hadn't been tested recently took part. The goal wa…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Study links vaginal germs to preterm birth risk
Knowledge-focused CompletedThis study followed 603 pregnant women in South Africa to see if infections or bacteria in the vagina are linked to how early they give birth. Researchers tested for sexually transmitted infections, yeast, and other germs at the start of pregnancy and again at 30-34 weeks. The go…
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:35 UTC